Mitchell S. Wortzman
University of California, Los Angeles
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mitchell S. Wortzman.
Journal of The American Academy of Dermatology | 1983
Nicholas J. Lowe; Mitchell S. Wortzman; James Breeding; Hala Koudsi; Linda Taylor
Recent studies have questioned the therapeutic value of coal tar versus ultraviolet (UV) radiation and their relative necessity in phototherapy for psoriasis. In this investigation, different aspects of tar phototherapy have been studied in single-blind bilateral paired comparison studies. The effects of 1% crude coal tar were compared with those of petrolatum in conjunction with erythemogenic and suberythemogenic doses of ultraviolet light (UVB) using a FS72 sunlamp tubed cabinet. Crude coal tar was clinically superior to petrolatum with suberythemogenic ultraviolet. With the erythemogenic UVB, petrolatum was equal in efficacy to crude coal tar. Suberythemogenic UVB was also used adjunctively to compare the effects of a 5% concentration of a tar extract in an oil base to 5% crude coal tar in petrolatum or the oil base without tar. The tar extract in oil plus suberythemogenic UVB produced significantly more rapid improvement than the oil base plus UVB. The direct bilateral comparison of equal concentrations of tar extract in oil base versus crude coal tar in petrolatum in a suberythemogenic UV photo regimen revealed no statistical differences between treatments. In a study comparing tar extract in oil and the oil base without ultraviolet radiation, the tar extract in oil side responded more rapidly. This demonstrates a direct effect of tar alone in therapy. We have also studied the effects of erythemogenic and suberythemogenic UVB with and without tar extract in oil in the hairless mouse epidermal deoxyribonucleic acid (DNA) synthesis suppression assay. It was found that erythemogenic dosages of UVB produced near maximal inhibition of DNA synthesis with or without coal tars. Suberythemogenic dosages of UVB produced submaximal suppression of DNA synthesis that was enhanced by adjunctive coal tar but not by vehicle, findings which are consistent with the above clinical results. These studies suggest that coal tars combined with suberythemogenic UVB therapy is a practical alternative (to more aggressive UVB therapy without coal tar) which reduces the UVB exposure to the patient.
British Journal of Dermatology | 1982
Nicholas J. Lowe; James Breeding; Mitchell S. Wortzman
Although crude coal tar is a mixture of approximately 10,000 components, few attempts have been made to assess the pharmacological activity of individual components of purified tar products or of different coal tars themselves. The hairless mouse epidermal DNA synthesis suppression assay, which has been shown to be useful for predicting the antiproliferative activity of topical agents, has recently been used to assess the activity of crude coal tar, coal tar extracts and tar based shampoos. Using this assay, great variation in effectiveness (0–90%) was found among tar distillate fractions, suggesting that one source of potential variation of activity in commercial coal tar products is the non‐standard composition of crude coal tar itself.
International Journal of Dermatology | 2010
Raza Aly; H. Irving Katz; Steven Kempers; Donald P. Lookingbill; Nicholas J. Lowe; Alan Menter; Manuel R. Morman; Ronald C. Savin; Mitchell S. Wortzman
Background Seborrheic dermatitis is a common inflammatory skin disorder that usually occurs in patients with pre‐existing seborrhea. The etiology of seborrheic dermatitis is uncertain. Typically, sites dense with sebaceous glands support growth of the lipophilic yeast Malassezia furfur. Ciclopirox (Loprox®) gel is a hydroxypyridone, broad‐spectrum antifungal agent proven effective against the yeast M. furfur.
International Journal of Dermatology | 2010
Raza Aly; George Fisher; H. Irving Katz; Norman Levine; Donald P. Lookingbill; Nicholas J. Lowe; Alan Menter; Manuel R. Morman; David M. Pariser; Harry L. Roth; Ronald C. Savin; Joel S. Shavin; Daniel Stewart; J. Richard Taylor; Stephen B. Tucker; Mitchell S. Wortzman
Background Tinea pedis (athlete’s foot) is the most common fungal infection in the general population. Ciclopirox, a broad‐spectrum hydroxypyridone antifungal, has proven efficacy against the organisms commonly implicated in tinea pedis: Trichophyton rubrum, T. mentagrophytes and Epidermophyton floccosum.
British Journal of Dermatology | 1984
Nicholas J. Lowe; Michael J. Connor; Richard E. Ashton; Mitchell S. Wortzman
It is possible to evaluate different dermatological therapeutic agents intended for human use in a variety of animal assays. This review will discuss some of these assays, and attempt to correlate animal and human skin responses.
Archive | 1986
Richard A. Scott; Mitchell S. Wortzman; Eric Jungermann
Archive | 1984
Richard A. Scott; Mitchell S. Wortzman; Eric Jungermann
Archive | 1986
Richard A. Scott; Mitchell S. Wortzman; Eric Jungermann
Archive | 1986
Richard A. Scott; Mitchell S. Wortzman; Eric Jungermann
Archives of Dermatology | 1982
Nicholas J. Lowe; James Breeding; Mitchell S. Wortzman